These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 35918217)

  • 21. Pre-synaptic C-terminal truncated tau is released from cortical synapses in Alzheimer's disease.
    Sokolow S; Henkins KM; Bilousova T; Gonzalez B; Vinters HV; Miller CA; Cornwell L; Poon WW; Gylys KH
    J Neurochem; 2015 May; 133(3):368-79. PubMed ID: 25393609
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanisms of synaptic dysfunction in Alzheimer's disease.
    Masliah E
    Histol Histopathol; 1995 Apr; 10(2):509-19. PubMed ID: 7599445
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mitochondrial Dysfunction and Synaptic Transmission Failure in Alzheimer's Disease.
    Guo L; Tian J; Du H
    J Alzheimers Dis; 2017; 57(4):1071-1086. PubMed ID: 27662318
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Amyloid β: linking synaptic plasticity failure to memory disruption in Alzheimer's disease.
    Ma T; Klann E
    J Neurochem; 2012 Jan; 120 Suppl 1(Suppl 1):140-148. PubMed ID: 22122128
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The role of α-synuclein in neurotransmission and synaptic plasticity.
    Cheng F; Vivacqua G; Yu S
    J Chem Neuroanat; 2011 Dec; 42(4):242-8. PubMed ID: 21167933
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Unique Properties of Synaptosomes and Prospects for Their Use for the Treatment of Alzheimer's Disease.
    Dashkova AS; Kovalev VI; Chaplygina AV; Zhdanova DY; Bobkova NV
    Biochemistry (Mosc); 2024 Jun; 89(6):1031-1044. PubMed ID: 38981699
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Melatonin in Synaptic Impairments of Alzheimer's Disease.
    Shi Y; Fang YY; Wei YP; Jiang Q; Zeng P; Tang N; Lu Y; Tian Q
    J Alzheimers Dis; 2018; 63(3):911-926. PubMed ID: 29710712
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synaptic dysfunction and septin protein family members in neurodegenerative diseases.
    Marttinen M; Kurkinen KM; Soininen H; Haapasalo A; Hiltunen M
    Mol Neurodegener; 2015 Apr; 10():16. PubMed ID: 25888325
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Mitochondrial Dysfunction Triggers Synaptic Deficits via Activation of p38 MAP Kinase Signaling in Differentiated Alzheimer's Disease Trans-Mitochondrial Cybrid Cells.
    Yu Q; Du F; Douglas JT; Yu H; Yan SS; Yan SF
    J Alzheimers Dis; 2017; 59(1):223-239. PubMed ID: 28598851
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Eph receptors at synapses: implications in neurodegenerative diseases.
    Chen Y; Fu AK; Ip NY
    Cell Signal; 2012 Mar; 24(3):606-11. PubMed ID: 22120527
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-synaptic scaffolding protein interactions with glutamate receptors in synaptic dysfunction and Alzheimer's disease.
    Proctor DT; Coulson EJ; Dodd PR
    Prog Neurobiol; 2011 Apr; 93(4):509-21. PubMed ID: 21382433
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Reactive Oxygen Species-Mediated Loss of Synaptic Akt1 Signaling Leads to Deficient Activity-Dependent Protein Translation Early in Alzheimer's Disease.
    Ahmad F; Singh K; Das D; Gowaikar R; Shaw E; Ramachandran A; Rupanagudi KV; Kommaddi RP; Bennett DA; Ravindranath V
    Antioxid Redox Signal; 2017 Dec; 27(16):1269-1280. PubMed ID: 28264587
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Synaptic dysfunction in Alzheimer's disease: Mechanisms and therapeutic strategies.
    Chen Y; Fu AKY; Ip NY
    Pharmacol Ther; 2019 Mar; 195():186-198. PubMed ID: 30439458
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Early Changes in Transcriptomic Profiles in Synaptodendrosomes Reveal Aberrant Synaptic Functions in Alzheimer's Disease.
    Qu X; Lin L; Yi W; Sun C; Chen Y; Chen Y
    Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012153
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Synaptic Impairment in Alzheimer's Disease: A Dysregulated Symphony.
    Forner S; Baglietto-Vargas D; Martini AC; Trujillo-Estrada L; LaFerla FM
    Trends Neurosci; 2017 Jun; 40(6):347-357. PubMed ID: 28494972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Synaptic Compensation as a Probable Cause of Prolonged Mild Cognitive Impairment in Alzheimer's Disease: Implications from a Transgenic Mouse Model of the Disease.
    Baazaoui N; Flory M; Iqbal K
    J Alzheimers Dis; 2017; 56(4):1385-1401. PubMed ID: 28222506
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deregulated mitochondrial microRNAs in Alzheimer's disease: Focus on synapse and mitochondria.
    Gowda P; Reddy PH; Kumar S
    Ageing Res Rev; 2022 Jan; 73():101529. PubMed ID: 34813976
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Serine Racemase Expression Differentiates Aging from Alzheimer's Brain.
    Wu S; Zhou J; Zhang H; Barger SW
    Curr Alzheimer Res; 2022; 19(7):494-502. PubMed ID: 35929621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Human Neural Stem Cells Reinforce Hippocampal Synaptic Network and Rescue Cognitive Deficits in a Mouse Model of Alzheimer's Disease.
    Zhang T; Ke W; Zhou X; Qian Y; Feng S; Wang R; Cui G; Tao R; Guo W; Duan Y; Zhang X; Cao X; Shu Y; Yue C; Jing N
    Stem Cell Reports; 2019 Dec; 13(6):1022-1037. PubMed ID: 31761676
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Functional Integrity of Synapses in the Central Nervous System of Cognitively Intact Individuals with High Alzheimer's Disease Neuropathology Is Associated with Absence of Synaptic Tau Oligomers.
    Singh A; Allen D; Fracassi A; Tumurbaatar B; Natarajan C; Scaduto P; Woltjer R; Kayed R; Limon A; Krishnan B; Taglialatela G
    J Alzheimers Dis; 2020; 78(4):1661-1678. PubMed ID: 33185603
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.